Influence of a 21-Gene Recurrence Score Assay on Chemotherapy Delivery in Breast Cancer

Gene expression profiling appears to account for a substantial amount of variability in CTx delivery in current practice. Further work is needed to ensure appropriate test usage and cost-effectiveness.